Brian Windsor
Board Member
Rein Therapeutics, Inc. (RNTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Brian Windsor
Brian Windsor is recorded as COO, CEO and Board Member at Rein Therapeutics, Inc. (RNTX). Rein Therapeutics, Inc. reported in an 8-K filed October 31, 2023 that Brian Windsor was appointed President and Chief Operating Officer. Rein Therapeutics, Inc. reported in an 8-K filed October 31, 2023 that Brian Windsor was appointed President and Chief Operating Officer, effective October 31, 2023. The proxy statement of Rein Therapeutics, Inc. reports total compensation of $882,695 for Brian Windsor in fiscal 2025, including a base salary of $575,000. Disclosed compensation is on record for 3 fiscal years.
“Brian Windsor, Ph.D, former Chief Executive Officer of Lung Tx, who was appointed as President and Chief Operating Officer of Aileron.”
“On October 30, 2023, the Board approved the appointment of Brian Windsor, Ph.D., age 57, to President and Chief Operating Officer of Aileron, effective as of the consummation of the Merger.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Current
Start not stated–present
-
Current
Start not stated–present
-
Start not stated–2023-10-31
-
Start not stated–2023-10-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Rein Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian Windsor, Ph.D. CEO, COO, Board Member
- Josef H. von Rickenbach Chairman, Board Member
- Charles Garner CFO
- Donald V. Dougherty CFO
- Timothy M. Cunningham CFO
- Manuel Aivado Chief Accounting Officer
- Alan A. Musso Board Member
- Manuel C. Alves-Aivado, M.D., Ph.D. Board Member
- Reinhard Ambros, Ph.D. Board Member
- Reinhard J. Ambros Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Rein Therapeutics, Inc. (RNTX) | President and Chief Executive Officer | $575,000 | $882,695 |
| 2024 | Rein Therapeutics, Inc. (RNTX) | President and Chief Executive Officer | $506,250 | $778,159 |
| 2023 | Rein Therapeutics, Inc. (RNTX) | President and Chief Executive Officer | $85,256 | $289,642 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.